Daewoong Co., Ltd. (003090.KS)
KRW 19660.0
(1.97%)
KRW 19660.0
(1.97%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3691.68 KRW | 49.65% |
| 2022 | 2466.88 KRW | 30.2% |
| 2021 | 1894.69 KRW | -19.14% |
| 2020 | 2343.12 KRW | 64.55% |
| 2019 | 1423.96 KRW | 105.77% |
| 2018 | 692.00 KRW | -54.89% |
| 2017 | 1534.00 KRW | 1567.39% |
| 2016 | 92.00 KRW | -89.85% |
| 2015 | 906.60 KRW | 62.24% |
| 2014 | 558.80 KRW | -41.99% |
| 2013 | 963.20 KRW | -8.35% |
| 2012 | 1051.00 KRW | 2.32% |
| 2011 | 1027.18 KRW | 33.69% |
| 2010 | 768.35 KRW | 61.71% |
| 2009 | 475.15 KRW | -42.22% |
| 2008 | 822.33 KRW | -19.16% |
| 2007 | 1017.28 KRW | 22.72% |
| 2006 | 828.93 KRW | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | 488.61 KRW | -5.33% |
| 2024 Q1 | 516.12 KRW | -44.17% |
| 2023 Q2 | 892.89 KRW | -3.4% |
| 2023 Q4 | 924.51 KRW | -1.67% |
| 2023 FY | - KRW | 49.65% |
| 2023 Q3 | 940.25 KRW | 5.3% |
| 2023 Q1 | 924.34 KRW | 3350.32% |
| 2022 Q2 | 770.22 KRW | 36.56% |
| 2022 FY | - KRW | 30.2% |
| 2022 Q4 | 26.79 KRW | -97.14% |
| 2022 Q3 | 935.65 KRW | 21.48% |
| 2022 Q1 | 564.00 KRW | -48.73% |
| 2021 Q3 | 646.00 KRW | 45.82% |
| 2021 FY | - KRW | -19.14% |
| 2021 Q1 | 75.00 KRW | -94.55% |
| 2021 Q2 | 443.00 KRW | 490.67% |
| 2021 Q4 | 1100.09 KRW | 70.29% |
| 2020 FY | - KRW | 64.55% |
| 2020 Q4 | 1376.87 KRW | 275.17% |
| 2020 Q1 | 371.00 KRW | 28.1% |
| 2020 Q2 | 249.00 KRW | -32.88% |
| 2020 Q3 | 367.00 KRW | 47.39% |
| 2019 FY | - KRW | 105.77% |
| 2019 Q4 | 289.61 KRW | 10.96% |
| 2019 Q1 | 277.00 KRW | 205.11% |
| 2019 Q3 | 261.00 KRW | -62.28% |
| 2019 Q2 | 692.00 KRW | 149.82% |
| 2018 FY | - KRW | -54.89% |
| 2018 Q1 | 335.00 KRW | -46.68% |
| 2018 Q2 | 294.00 KRW | -12.24% |
| 2018 Q4 | -263.54 KRW | -180.84% |
| 2018 Q3 | 326.00 KRW | 10.88% |
| 2017 Q4 | 628.31 KRW | 92.14% |
| 2017 Q2 | 283.00 KRW | -4.39% |
| 2017 FY | - KRW | 1567.39% |
| 2017 Q3 | 327.00 KRW | 15.55% |
| 2017 Q1 | 296.00 KRW | -44.83% |
| 2016 FY | - KRW | -89.85% |
| 2016 Q2 | -12.80 KRW | 65.41% |
| 2016 Q4 | 536.49 KRW | 136.13% |
| 2016 Q1 | -37.00 KRW | -139.36% |
| 2016 Q3 | 227.20 KRW | 1875.0% |
| 2015 Q4 | 94.00 KRW | -60.54% |
| 2015 Q2 | 280.40 KRW | 6.05% |
| 2015 FY | - KRW | 62.24% |
| 2015 Q1 | 264.40 KRW | 264.74% |
| 2015 Q3 | 238.20 KRW | -15.05% |
| 2014 Q4 | 72.49 KRW | 119.67% |
| 2014 FY | - KRW | -41.99% |
| 2014 Q3 | 33.00 KRW | -85.63% |
| 2014 Q2 | 229.60 KRW | -7.64% |
| 2014 Q1 | 248.60 KRW | -35.03% |
| 2013 FY | - KRW | -8.35% |
| 2013 Q2 | 337.20 KRW | 39.57% |
| 2013 Q3 | 297.60 KRW | -11.74% |
| 2013 Q4 | 382.61 KRW | 28.57% |
| 2013 Q1 | 241.60 KRW | 181.36% |
| 2012 Q1 | 361.80 KRW | 850.6% |
| 2012 FY | - KRW | 2.32% |
| 2012 Q4 | -296.97 KRW | -208.23% |
| 2012 Q3 | 274.40 KRW | -28.24% |
| 2012 Q2 | 382.40 KRW | 5.69% |
| 2011 Q1 | 98.06 KRW | 0.0% |
| 2011 FY | - KRW | 33.69% |
| 2011 Q4 | 38.06 KRW | -27.67% |
| 2011 Q3 | 52.62 KRW | 30.28% |
| 2011 Q2 | 40.39 KRW | -58.81% |
| 2010 Q1 | 161.55 KRW | -43.29% |
| 2010 FY | - KRW | 61.71% |
| 2010 Q2 | 52.82 KRW | -67.3% |
| 2010 Q3 | 223.30 KRW | 322.76% |
| 2009 Q3 | 38.83 KRW | -86.25% |
| 2009 FY | - KRW | -42.22% |
| 2009 Q1 | 335.73 KRW | 87.94% |
| 2009 Q2 | 282.33 KRW | -15.91% |
| 2009 Q4 | 284.85 KRW | 633.58% |
| 2008 Q4 | 178.64 KRW | 166.67% |
| 2008 Q1 | 372.73 KRW | 45.52% |
| 2008 Q3 | 66.99 KRW | -72.9% |
| 2008 Q2 | 247.18 KRW | -33.68% |
| 2008 FY | - KRW | -19.16% |
| 2007 Q2 | 225.72 KRW | 0.0% |
| 2007 Q4 | 256.14 KRW | 9.74% |
| 2007 FY | - KRW | 22.72% |
| 2007 Q3 | 233.40 KRW | 3.4% |
| 2006 FY | - KRW | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| PharmGen Science, Inc. | 351.99 KRW | -948.803% |
| Wooridul Huebrain Limited | -138.00 KRW | 2775.13% |